Hawkins, Inc. $HWKN Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC reduced its position in Hawkins, Inc. (NASDAQ:HWKN) by 74.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,338 shares of the specialty chemicals company’s stock after selling 38,454 shares during the period. Allspring Global Investments Holdings LLC owned about 0.06% of Hawkins worth $2,376,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in Hawkins during the second quarter worth about $31,000. GAMMA Investing LLC grew its stake in shares of Hawkins by 24.1% in the second quarter. GAMMA Investing LLC now owns 659 shares of the specialty chemicals company’s stock worth $94,000 after acquiring an additional 128 shares in the last quarter. Ethic Inc. acquired a new position in Hawkins during the 2nd quarter worth $205,000. Evergreen Capital Management LLC purchased a new position in Hawkins in the second quarter worth approximately $208,000. Finally, ZWJ Investment Counsel Inc. purchased a new stake in shares of Hawkins during the 3rd quarter worth approximately $211,000. 69.71% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Hawkins

In other news, VP Drew M. Grahek purchased 1,587 shares of Hawkins stock in a transaction dated Monday, November 3rd. The stock was bought at an average price of $126.34 per share, with a total value of $200,501.58. Following the completion of the acquisition, the vice president owned 39,640 shares in the company, valued at $5,008,117.60. The trade was a 4.17% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 4.10% of the company’s stock.

Hawkins Stock Performance

Hawkins stock opened at $153.69 on Friday. The stock’s 50 day moving average price is $137.11 and its 200 day moving average price is $155.91. The firm has a market capitalization of $3.21 billion, a PE ratio of 38.62, a price-to-earnings-growth ratio of 2.29 and a beta of 0.86. Hawkins, Inc. has a one year low of $98.30 and a one year high of $186.15. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 2.43.

Hawkins (NASDAQ:HWKN) last announced its earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.24 by ($0.16). Hawkins had a net margin of 7.95% and a return on equity of 17.42%. The business had revenue of $280.43 million during the quarter, compared to analyst estimates of $284.42 million. As a group, sell-side analysts expect that Hawkins, Inc. will post 4 EPS for the current fiscal year.

Hawkins Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Friday, November 14th were given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Friday, November 14th. Hawkins’s dividend payout ratio is presently 19.10%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on HWKN. Zacks Research raised Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Weiss Ratings reissued a “buy (b-)” rating on shares of Hawkins in a report on Monday, December 29th. Finally, BWS Financial restated a “buy” rating and set a $200.00 target price on shares of Hawkins in a research report on Monday, November 3rd. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Hawkins presently has a consensus rating of “Moderate Buy” and a consensus price target of $162.50.

Hawkins Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.